Clinical Validation of Suntech Advantage MX With Suntech Neonate and Children Cuff Line

首次发布于 2023 年 12 月 15 日

SEarchiNg BiomarkErs Cerebral Amyloid Angiopathy (SENECA)

计划入组 500 人 · 首次发布于 2019 年 12 月 19 日

SENECA - Smart Therapies for Chronic Pain

计划入组 44 人 · 首次发布于 2026 年 6 月 4 日

SUPLEXA

SUPLEXA cell therapy (Alloplex Biotherapeutics)

UNDECA-3,7-DIENE-1,3,7,11-TETRACARBALDEHYDE

C₁₅H₂₀O₄

SUNEVA MEDICAL, INC.

United States

SUNTEC PHARMACEUTICALS PTY LTD

Australia

FDA Places Clinical Hold on Gilead's Weekly HIV Combination Therapy Following Safety Signal

FDA Approves Sunlenca (Lenacapavir), a First-in-Class HIV-1 Capsid Inhibitor

SUPLEXA Personalized Immunotherapy Shows Promise in Advanced Cancer Trial